Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition characterized by low levels of alpha-1 antitrypsin (AAT) protein in the blood, leading to an increased risk of lung and liver diseases. AATD primarily affects the lungs, predisposing individuals to chronic obstructive pulmonary disease (COPD), emphysema, and other respiratory complications. The AATD treatment market encompasses a...